Walia A, Sun Y, Acharya NR. Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination. JAMA Ophthalmol. 2024 Feb 15:e236830. doi: 10.1001/jamaophthalmol.2023.6830. Epub ahead of print. PMID: 38358762; PMCID: PMC10870220. 遺伝子組換え帯状疱疹ワクチン（RZV）は現在、50歳以上の成人および19歳以上の免疫不全成人に推奨されており、眼部帯状疱疹（HZO）の予防に有効である。しかし、HZOの既往がある患者におけるRZVの安全性については疑問が残ります。
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast
Fox News Crashes Out on Air Over Trump’s Rapid Fall
07 Dec 2025
The MeidasTouch Podcast